Hantavirus in humans: a review of clinical aspects and management
Journal
The Lancet Infectious Diseases
ISSN
1473-3099
Date Issued
2023
Author(s)
Marcela Ferrés
Jonas Klingström
Clas Ahlm
Nicole Le Corre
Gregory J Mertz
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Cite this document
Vial, P. A., Ferrés, M., Vial, C., Klingström, J., Ahlm, C., López, R., Le Corre, N., & Mertz, G. J. (2023). Hantavirus in humans: A review of clinical aspects and management. The Lancet Infectious Diseases, 23(9), e371-e382. https://doi.org/10.1016/S1473-3099(23)00128-7
Subjects
communicable diseases
;
endothelial cells
;
hantavirus infections
;
hantavirus pulmonary syndrome
;
hemorrhagic fever with renal syndrome
;
humans
;
orthohantavirus
;
antivirus agent
;
favipiravir
;
icatibant
;
inactivated virus vaccine
;
neutralizing antibody
;
ribavirin
;
andes virus
;
asia
;
case fatality rate
;
clinical feature
;
clinical outcome
;
differential diagnosis
;
endemic disease
;
europe
;
extracorporeal oxygenation
;
hantavirus pulmonary syndrome
;
hemorrhagic fever with renal syndrome
;
host pathogen interaction
;
human
;
infectious pregnancy complications
;
intensive care unit
;
newborn
;
nonhuman
;
organ systems
;
pediatric patient
;
post exposure prophylaxis
;
pregnancy outcome
;
real time polymerase chain reaction
;
review
;
rodent
;
seoul virus
;
serology
;
supportive care need
;
treatment indication
;
virus cell interaction
;
virus diagnosis
;
western hemisphere
;
communicable disease
;
endothelium cell
;
hantavirus
;
hantavirus infection
;
hantavirus pulmonary syndrome
;
hemorrhagic fever with renal syndrome
;
pathology